Article Text

Download PDFPDF

Complement activation by anticardiolipin antibodies.
  1. M B Santiago,
  2. N Gaburo, Jr,
  3. R M de Oliveira,
  4. W Cossermelli
  1. Laboratory of Investigation in Rheumatology, University of São Paulo, School of Medicine, Brazil.


    A haemolytic assay was used to test the complement fixation ability of 16 serum samples with high concentrations of anti-cardiolipin antibodies. Fourteen patients had clinical complications usually associated with these antibodies--namely, recurrent abortions, thrombosis, or thrombocytopenia. Complement fixation by anticardiolipin antibodies was shown in only four of these patients and was not directly related to the antibody concentration. Because anticardiolipin antibodies in most of these patients did not activate the complement pathway it is unlikely that the complement cascade has an important role in the clinical complications associated with these antibodies.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.